Similar articles

• Estimation of relative risk from vital data: smoking and cancers of the lung and bladder.

  Stevens RG, Moolgavkar SH. Stevens RG, et al. J Natl Cancer Inst. 1979 Dec;63(6):1351-7. J Natl Cancer Inst. 1979. PMID: 292807
• [Cancers related to tobacco smoking].

  Benhamou S. Benhamou S. Rev Prat. 1993 May 15;43(10):1214-7. Rev Prat. 1993. PMID: 8235357 Review. French.
• Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.

  Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E. Salagovic J, et al. Neoplasma. 1998;45(5):312-7. Neoplasma. 1998. PMID: 9921921
• [Tar exposure in tobacco-associated lung and bladder neoplasms].

  Kunze M, Vutuc C. Kunze M, et al. MMW Munch Med Wochenschr. 1979 Aug 10;121(32-33):1041-2. MMW Munch Med Wochenschr. 1979. PMID: 112465 German. No abstract available.
• The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation.

  Strope SA, Montie JE. Strope SA, et al. J Urol. 2008 Jul;180(1):31-7; discussion 37. doi: 10.1016/j.juro.2008.03.045. Epub 2008 May 15. J Urol. 2008. PMID: 18485400 Review.